NCT01641965View on ClinicalTrials.gov

Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DEVICE

Home pressure ventilator model Vivo 40 (BREAS Medical AB)

Nocturnal non invasive ventilation (Vivo 40)with minimum pressure support of 10 cm H2O (IPAP 14, EPAP 4). Parameters will be adjusted according to tolerance and to achieve PaCO2 \< 45 mmHg and improve symptoms.

Trial Locations (1)

08907

Hospital Universitari Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Fondo de Investigacion Sanitaria

OTHER

lead

Hospital Universitari de Bellvitge

OTHER

NCT01641965 - Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients | Biotech Hunter | Biotech Hunter